MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS) — Franz Fazekas (2005) | RDL Network
The absence of significant differences in conventional MRI measures between both treatment groups parallels the negative clinical results of ESIMS. The causes for and possible long-term clinical effects of a lower rate of brain volume loss in IVIG patients should be explored further.
P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller
Marco Rovaris, Elda Judica, Jaume Sastre‐Garriga, Àlex Rovira, Maria Pia Sormani, Béatrice Benedetti, Tijmen Korteweg, Nicola De Stefano, Zhaleh Khaleeli, Xavier Montalbán, Frederik Barkhof, David H. Miller, Chris H. Polman, Alan J. Thompson, Massimo Filippi
S. J. Camp, V L Stevenson, Alan J. Thompson, David H. Miller, Cecilia Borrás, Sophie Auriacombe, Bruno Brochet, Monica Falautano, Massimo Filippi, L. Herisse-Dulo, Xavier Montalbán, E. Parrcira, Chris H. Polman, Jong Mechteld De, Dawn Langdon
Maria A. Rocca, Maria Pia Sormani, Marco Rovaris, Domenico Caputo, Angelo Ghezzi, Enrico Montanari, Antonio Bertolotto, Alice Laroni, Roberto Bergamaschi, Vittorio Martinelli, Gıancarlo Comı, Massimo Filippi
Discussion(0)
No comments yet. Be the first to comment.